Premarket Innovators And SMEs (Part 2): Running Out Of Time In The EU MDR Race
In the medtech industry, who is most vulnerable in the run up to the EU MDR’s 26 May deadline?
Executive Summary
In this second article of a two-part series, Eithne Lee of ISO Life Sciences global consultancy identifies some of the problems that medtech premarket innovators and SMEs are facing, with the EU MDR application date now less than four months away.